Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Details:
Under the agreement, the 7 selected generic manufacturers will manufacture and supply Xocova (ensitrelvir fumaric acid), an oral antiviral drug for COVID-19 recently approved in Japan, in 117 low and middle income countries.
Lead Product(s): Ensitrelvir Fumaric Acid
Therapeutic Area: Infections and Infectious Diseases Product Name: Xocova
Highest Development Status: ApprovedProduct Type: Small molecule
Recipient: Shionogi
Deal Size: Undisclosed Upfront Cash: Undisclosed
Deal Type: Licensing Agreement June 26, 2023